User contributions for Tejasvi Aryaputra

29 December 2022

• 21:1621:16, 29 December 2022 diff hist +5,755‎ Asparaginase erwinia chrysanthemi (recombinant)-rywn ‎No edit summary
• 19:1219:12, 29 December 2022 diff hist +6,304‎ N Asparaginase erwinia chrysanthemi (recombinant)-rywn ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Asparaginase erwinia chrysanthemi (recombinant)-rywn |aOrAn=an |drugClass=asparagine specific enzyme |indicationType=treatment |indication=acute lymphoblastic leukemia and lymphoblastic lymphoma in patients who are allergic to E. coli-derived asparaginase products, as a component of a chemotherapy regimen |adverseReactions=musculoskeletal pain, febrile neutropenia, hypokalemia, abnorm..."

12 September 2022

• 00:0900:09, 12 September 2022 diff hist +5,125‎ Finerenone ‎No edit summary current

6 September 2022

• 00:1600:16, 6 September 2022 diff hist 0‎ N File:Finerenone Table 4 Clinical Studies.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Table 3 Adverse Reactions.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Table 2 Dosage Adjustments.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Table 1 Dosage.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Structure 2.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Structure.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Figure 2 Clinical Studies.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Figure 1 Clincal Studies.png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Drug Label (20 mg).png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Drug Label (10 mg).png ‎No edit summary current
• 00:1500:15, 6 September 2022 diff hist 0‎ N File:Finerenone Drug Info Pt.3.png ‎No edit summary current
• 00:1400:14, 6 September 2022 diff hist 0‎ N File:Finerenone Drug Info Pt.2.png ‎No edit summary current
• 00:1400:14, 6 September 2022 diff hist 0‎ N File:Finerenone Drug Info.png ‎No edit summary current

5 September 2022

• 21:0421:04, 5 September 2022 diff hist +2,463‎ Finerenone ‎No edit summary
• 05:4005:40, 5 September 2022 diff hist +10,703‎ N Finerenone ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Finerenone |aOrAn=a |drugClass=mineralocorticoid receptor antagonist |indicationType=prophylaxis |indication=the risk of kidney and heart complications in chronic kidney disease associated with type 2 diabetes |adverseReactions=hypotension, hyperkalemia, and hyponatremia |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF00..."
• 02:3402:34, 5 September 2022 diff hist +4,777‎ Fexinidazole ‎No edit summary current
• 02:1102:11, 5 September 2022 diff hist 0‎ N File:Fexinidazole Table 6 Success Rate.png ‎No edit summary current
• 02:1102:11, 5 September 2022 diff hist 0‎ N File:Fexinidazole Table 5 Pharmocokinetics.png ‎No edit summary current
• 02:1002:10, 5 September 2022 diff hist 0‎ N File:Fexinidazole Table 4 Drug Interactions Pt.4.png ‎No edit summary current
• 02:1002:10, 5 September 2022 diff hist 0‎ N File:Fexinidazole Table 3 Drug Interactions Pt.1.png ‎No edit summary current
• 02:1002:10, 5 September 2022 diff hist 0‎ N File:Fexinidazole Table 2 Adverse Reactions Pt.2.png ‎No edit summary current
• 02:1002:10, 5 September 2022 diff hist 0‎ N File:Fexinidazole Table 2 Adverse Reactions.png ‎No edit summary current
• 02:1002:10, 5 September 2022 diff hist 0‎ N File:Fexinidazole Table 1 Dosage.png ‎No edit summary current
• 02:1002:10, 5 September 2022 diff hist 0‎ N File:Fexinidazole Packaging Label.png ‎No edit summary current
• 02:1002:10, 5 September 2022 diff hist 0‎ N File:Fexinidazole Packaging Info Pt.2.png ‎No edit summary current
• 02:0902:09, 5 September 2022 diff hist 0‎ N File:Fexinidazole Packaging Info Pt.1.png ‎No edit summary current
• 02:0902:09, 5 September 2022 diff hist 0‎ N File:Fexinidazole Chemical Structure Pt.2.png ‎No edit summary current
• 02:0902:09, 5 September 2022 diff hist 0‎ N File:Fexinidazole Chemical Structure.png ‎No edit summary current
• 02:0802:08, 5 September 2022 diff hist +6,437‎ Belumosudil ‎No edit summary current
• 01:3201:32, 5 September 2022 diff hist +15,982‎ N Fexinidazole ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Fexinidazole |aOrAn=a |drugClass=nitroimidazole antimicrobial |indicationType=treatment |indication=human African trypanosomiasis caused by the parasite Trypanosoma brucei gambiense |adverseReactions=hypocalcemia, upper abdominal pain, insomnia, dyspepsia, decreased appetite, hyperkalemia, back pain, nausea, dizziness, asthenia, tremor, and headache...."

30 August 2022

• 01:3401:34, 30 August 2022 diff hist 0‎ N File:Belumosudil Table 2 Adverse Reactions.png ‎No edit summary current
• 01:3301:33, 30 August 2022 diff hist 0‎ N File:Belumosudil Table 5 Clinical Data.png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Table 4 Patient Pop.png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Table 3 Lab Abnormalties.png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Table 2 Adverse Reactions Pt. 2.png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Table 1 Dosage.png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Structure 2.png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Structure.png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Package Insert Pt.2 .png ‎No edit summary current
• 01:3201:32, 30 August 2022 diff hist 0‎ N File:Belumosudil Package Insert.png ‎No edit summary current
• 01:3101:31, 30 August 2022 diff hist 0‎ N File:Belumosudil Drug Label.png ‎No edit summary current
• 01:3101:31, 30 August 2022 diff hist 0‎ N File:Belumosudil Drug Insert Pt.2.png ‎No edit summary current
• 01:3101:31, 30 August 2022 diff hist 0‎ N File:Belumosudil Drug Insert.png ‎No edit summary current
• 01:2501:25, 30 August 2022 diff hist +5,821‎ Odevixibat ‎No edit summary current
• 01:1301:13, 30 August 2022 diff hist 0‎ N File:Odevixibat Structure.png ‎No edit summary current
• 00:5500:55, 30 August 2022 diff hist +3,257‎ Belumosudil ‎No edit summary
• 00:2000:20, 30 August 2022 diff hist +11,664‎ N Belumosudil ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Belumosudil |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy |adverseReactions=dyspnea, asthenia, phosphate decrease, hypertension, cough, nausea, lymphocytes decreased, edema, diarrhea, glutamyl transferase increased,, hemorrhage, h..."